- Fund Type: Open-End Fund
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
BlackRock Health Sciences Opportunities Portfolio
+ Add to WatchlistSHSAX:US
38.72 USD 0.06 0.15%As of 20:00:00 ET on 05/23/2013.
Snapshot for BlackRock Health Sciences Opportunities Portfolio (SHSAX)
| Year To Date: | +23.23% | 3-Month: | +12.99% | 3-Year: | +19.47% | 52-Week Range: | 27.58 - 39.16 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +1.02% | 1-Year: | +37.86% | 5-Year: | +13.32% | Beta vs SPX: | 0.85 |
Fund Profile & Information for SHSAX
BlackRock Health Sciences Opportunities Portfolio is an open-end fund incorporated in the USA. The Fund's objective is long-term growth of capital. The Fund normally invests at least 80% of total assets in securities of companies in health sciences and related industries.
| Inception Date: | 12-21-1999 | Telephone: | 1-800-441-7762 |
|---|---|---|---|
| Managers: | THOMAS P CALLAN / H ERIN XIE | ||
| Web Site: | www.blackrock.com | ||
Fundamentals for SHSAX
| NAV | (on 2013-05-23) 38.72 |
|---|---|
| Assets (M) | (on 2013-05-23) 2,660.78 |
| Fund Leveraged | N |
| Minimum Investment | 1,000.00 |
| Minimum Subsequent Investment | 50.00 |
Dividends for SHSAX
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Irreg |
| Last Dividend Net | (on 2012-12-12) 0.10 |
| Dividend Yield (ttm) | 6.01 |
Fees & Expenses for SHSAX
| Front Load | 5.25 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 0.73 |
| Redemption Fee | 0.00 |
| 12b1 Fee | 0.25 |
| Expense Ratio | 1.28 |
Top Fund Holdings for SHSAX
Filing Date: 12/31/2012| Name | Position | Value | % of Total |
|---|---|---|---|
| Pfizer Inc | 4,340,140 | 108,850,711 | 5.513% |
| Eli Lilly & Co | 1,603,600 | 79,089,552 | 4.005% |
| Johnson & Johnson | 1,043,900 | 73,177,390 | 3.706% |
| Roche Holding AG | 353,600 | 71,491,268 | 3.621% |
| Sanofi | 735,200 | 69,719,311 | 3.531% |
| Celgene Corp | 748,152 | 58,894,525 | 2.983% |
| Novartis AG | 833,900 | 52,680,203 | 2.668% |
| Express Scripts Holding Co | 920,447 | 49,704,138 | 2.517% |
| Alexion Pharmaceuticals Inc | 495,101 | 46,445,425 | 2.352% |
| Biogen Idec Inc | 309,400 | 45,379,698 | 2.298% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page